Steven M Greenberg Selected Research

Steven M Greenberg Research Topics

Disease

85	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 04/2024 - 01/2002
62	Cerebral Hemorrhage 03/2024 - 07/2003
31	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2006
28	Hemorrhage 05/2024 - 04/2004
20	Stroke (Strokes) 12/2023 - 09/2005
16	Cognitive Dysfunction 01/2023 - 11/2004
16	Hematoma 01/2019 - 12/2005
15	Dementia (Dementias) 01/2023 - 01/2002
12	Familial Cerebral Amyloid Angiopathy 07/2023 - 07/2008
12	Hemorrhagic Stroke 01/2021 - 01/2002
10	Ischemic Stroke 11/2023 - 07/2008
8	Siderosis 05/2024 - 07/2011
8	Cerebral Small Vessel Diseases 04/2024 - 10/2016
8	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2024 - 05/2011
8	Atrial Fibrillation 12/2023 - 07/2003
7	Disease Progression 02/2024 - 08/2011
7	Amyloid Plaque 01/2023 - 07/2005
7	Inflammation (Inflammations) 01/2022 - 02/2004
6	Brain Injuries (Brain Injury) 01/2023 - 11/2013
5	Hypertension (High Blood Pressure) 11/2022 - 12/2011
5	Edema (Dropsy) 04/2019 - 12/2005
4	App-Related Cerebroarterial Amyloidosis 03/2024 - 10/2019
4	Amyloidosis 12/2023 - 09/2008
3	Leukoencephalopathies 01/2022 - 04/2013
3	Rupture 01/2021 - 01/2009
3	Leukoaraiosis 01/2018 - 04/2013
3	Amyloid angiopathy 01/2017 - 03/2003
3	Diabetes Mellitus 01/2014 - 04/2004
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012 - 11/2004
3	Heart Failure 02/2009 - 10/2006
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2023 - 01/2018
2	Gliosis 08/2023 - 06/2015
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2023 - 07/2008
2	Thromboembolism 01/2020 - 12/2008
2	Embolic Stroke 11/2018 - 04/2004
2	Atrophy 01/2018 - 01/2016
1	Neuroinflammatory Diseases 08/2023
1	Pathologic Processes 01/2023
1	Cavernous Hemangioma (Cavernous Angioma) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Aphasia (Dysphasia) 04/2019
1	Subdural Hematoma (Subdural Hemorrhage) 04/2019

Drug/Important Bio-Agent (IBA)

62	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2002
33	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2009
19	Amyloid beta-PeptidesIBA 03/2021 - 01/2002
19	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 07/2003
17	Apolipoproteins E (ApoE)IBA 11/2022 - 12/2010
12	AnticoagulantsIBA 11/2023 - 07/2003
10	Peptides (Polypeptides)IBA 01/2023 - 01/2002
9	ApolipoproteinsIBA 08/2020 - 06/2012
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 06/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
6	IronIBA 05/2024 - 01/2018
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 12/2005
5	LipidsIBA 12/2023 - 01/2014
5	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 12/2005
5	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019 - 11/2008
4	Hemostatics (Antihemorrhagics)IBA 11/2014 - 08/2008
3	Hemoglobins (Hemoglobin)IBA 11/2023 - 01/2019
3	Dabigatran FDA Link 11/2023 - 01/2011
3	CalciumIBA 01/2023 - 11/2016
3	CholesterolIBA 01/2021 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 09/2009
3	HemosiderinIBA 01/2014 - 07/2011
2	Minocycline (Cyclops)FDA LinkGeneric 02/2024 - 06/2015
2	aducanumabIBA 01/2022 - 01/2021
2	Nerve Growth Factors (Neurotrophins)IBA 11/2021 - 01/2021
2	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 11/2021 - 01/2021
2	FibrinIBA 01/2021 - 01/2019
2	CreatinineIBA 01/2021 - 01/2018
2	HDL CholesterolIBA 11/2016 - 01/2014
2	Genetic Markers (Genetic Marker)IBA 10/2016 - 12/2008
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2015 - 09/2006
2	recombinant FVIIa (rFVIIa)FDA Link 01/2013 - 09/2006
2	Collagen Type IV (Type IV Collagen)IBA 04/2012 - 07/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011 - 11/2004
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2023
1	N(4)-oleylcytosine arabinosideIBA 11/2023
1	Vitamin K FDA Link 11/2023
1	apixabanIBA 11/2023
1	Matrix Metalloproteinase InhibitorsIBA 01/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Waste Products (Waste Product)IBA 01/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	AN-1792IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2020
1	ponezumabIBA 04/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	estropipate (Ogen)FDA LinkGeneric 01/2019
1	Labetalol (Normodyne)FDA LinkGeneric 01/2019
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019

Therapy/Procedure

24	Therapeutics 01/2022 - 07/2003
4	Secondary Prevention 12/2023 - 05/2011
4	Immunotherapy 01/2022 - 02/2007
1	Blood Transfusion (Blood Transfusions) 12/2023
1	Off-Label Use 01/2021